Does the Piperacillin Minimum Inhibitory Concentration for Pseudomonas aeruginosa Influence Clinical Outcomes of Children With Pseudomonal Bacteremia?

Background. The Clinical and Laboratory Standards Institute (CLSI) recently elected to adjust the previous piperacillin susceptibility breakpoint of ≤64 µg/mL against Pseudomonas aeruginosa to ≤16 µg/mL, based largely on pharmacokinetic–pharmacodynamic (PK–PD) modeling studies. Data on whether PK–PD...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tamma, Pranita D., Turnbull, Alison E., Milstone, Aaron M., Hsu, Alice J., Carroll, Karen C., Cosgrove, Sara E.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2012
Assuntos:
Articles and Commentaries
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3657512/
https://ncbi.nlm.nih.gov/pubmed/22696019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cis545
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados